A carregar...
Efficacy of Transdermal Oxybutynin in the Treatment of Overactive Bladder Syndrome: Does It Make Sense Using It in 2017?
OBJECTIVES: Evaluation of changes in symptoms among patients with overactive bladder syndrome treated with transdermal oxybutynin and tolerability after 12 months of follow-up. METHODS: This was a multicenter, retrospective, single-cohort, observational study. Changes in symptoms were evaluated prim...
Na minha lista:
| Publicado no: | Adv Urol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6087608/ https://ncbi.nlm.nih.gov/pubmed/30151004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/6782736 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|